Pediatric Endocrinology Diabetes and Metabolism
en ENGLISH
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

without publication fees

Zintegrowane z publons

integrated with publons
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
Artykuł oryginalny

Kwasica ketonowa w przebiegu nowo rozpoznanej cukrzycy typu 1 – czy obserwujemy powrót do sytuacji sprzed pandemii COVID-19?

Rita Gomes Alvelos
1, 2
,
Paula Santos
2, 3
,
Mariana Sebastião
2
,
Catarina Tavares
2, 4
,
Inês Barros Rua
2
,
Joana Serra-Caetano
2
,
Rita Cardoso
2
,
Isabel Dinis
2
,
Alice Mirante
2

  1. Department of Paediatrics, Unidade Local de Saúde Região de Aveiro, Portugal
  2. Paediatric Endocrinology, Diabetes and Growth Unit, Hospital Pediátrico de Coimbra, Unidade Local de Saúde de Coimbra, Portugal
  3. Department of Paediatrics, Unidade Local de Saúde do Médio Tejo, Torres Novas, Portugal
  4. Department of Paediatrics, Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal
Pediatr Endocrinol Diabetes Metab 2026; 32 (1): 32-37
DOI: https://doi.org/10.5114/pedm.2026.159708
Data publikacji online: 2026/03/30
Plik artykułu:
- 0421_Ketoacidosis in new-onset.pdf  [0.83 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Ogle GD, Wang F, Gregory GA, Maniam J. Type 1 diabetes estimates in children and adults – 2022. Diabetes Atlas 2022. Available at: https://www.diabetesatlas.org.
2. Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet 2016; 387: 2340–2348. doi: 10.1016/S0140-6736(16)30507-4.
3. Al Otaibi AA, Aljahadali HMH, Almutairi RA. Diabetic ketoacidosis: a common complication of diabetes mellitus – diagnosis, treatment, and interventions – an updated review article. J Int Crisis Risk Commun Res 2024; 7: 2408–2416. doi: 10.63278/jicrcr.vi.1671.
4. Rahmati M, Keshvari M, Mirnasuri S, et al. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol 2022; 94: 5112–5127. doi: 10.1002/jmv.27996.
5. Adil MT, Rahman R, Whitelaw D, et al. SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J 2021; 97: 110–116. doi: 10.1136/postgradmedj-2020-138386.
6. Koca SB, Takcı MZ, Deniz R, et al. Change in the frequency of diabetic ketoacidosis in children with newly diagnosed type 1 diabetes in the Central Anatolia region of Turkey over the years before and after the coronavirus disease 2019 pandemic: a single-center experience. Turk Arch Pediatr 2024; 59: 163–169. doi: 10.5152/TurkArchPediatr.2024.23255.
7. Botelho TA, Santos JMN, Pinho CMS, et al. Ketoacidosis in new-onset type 1 diabetes: did the severity increase during the COVID-19 pandemic? J Pediatr Endocrinol Metab 2022; 35: 73–77. doi: 10.1515/jpem-2021-0449.
8. Karavanaki K, Rodolaki K, Soldatou A, et al. COVID-19 infection in children and adolescents and its association with type 1 diabetes mellitus presentation and management. Endocrine 2023; 80: 237–252. doi: 10.1007/s12020-022-03266-7.
9. Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr 2020; 14: 2211–2217. doi: 10.1016/j.dsx.2020.11.012.
10. Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 2022; 23: 835–856. doi: 10.1111/pedi.13406.
11. Boboc AA, Novac CN, Marin AG, et al. SARS-CoV-2 positive serology and islet autoantibodies in newly diagnosed pediatric cases of type 1 diabetes mellitus: a single-center cohort study. Int J Mol Sci 2023; 24: 8885. doi: 10.3390/ijms24108885.
12. Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the UK. Diabetes Care 2020; 43: e170–e171. doi: 10.2337/dc20-1551.
13. Agarwal A, Bansal D, Nallasamy K, et al. Pediatric diabetes and diabetic ketoacidosis after COVID-19: challenges faced and lessons learnt. Pediatr Health Med Ther 2023; 14: 281–288. doi: 10.2147/PHMT.S384104.
14. Birkebaek N, Kamrath C, Grimsmann J, et al. Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries. Lancet Diabetes Endocrinol 2022; 10: 786–794. doi: 10.1016/S2213-8587(22)00246-7.
15. Cherubini V, Grimsmann JM, Åkesson K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia 2020; 63: 1530–1541.  doi: 10.1007/s00125-020-05152-1.
16. Ho J, Rosolowsky E, Pacaud D, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes 2021; 22: 552–557. doi: 10.1111/pedi.13205.
17. Raab J, Haupt F, Scholz M, et al. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open 2016; 6: e011144. doi: 10.1136/bmjopen-2016-011144.
18. Sims EK, Besser REJ, Dayan C, et al. Screening for type 1 diabetes in the general population: a status report and perspective. Diabetes 2022; 71: 610–623. doi: 10.2337/dbi21-0054.
19. Scudder C, Townson J, Bowen-Morris J, et al. General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study). Arch Dis Child 2024; 109: 812–817. doi: 10.1136/archdischild-2023-326697.
20. Simmons KM, Sims EK. Screening and prevention of type 1 diabetes: where are we? J Clin Endocrinol Metab 2023; 108: 3067–3079. doi: 10.1210/clinem/dgad328.
21. Hummel S, Carl J, Friedl N, et al. Children diagnosed with pre-symptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia 2023; 66: 1633–1642. doi: 10.1007/s00125-023-05953-0.
22. Philip M, Achenbach P, Addala A, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024; 47: 1276–1298. doi: 10.2337/dci24-0042.
23. Scheiner G, Weiner S, Kruger DF, Pettus J. Screening for type 1 diabetes: role of the diabetes care and education specialist. ADCES Pract 2022; 10: 20–25. doi:10.1177/2633559X221110216.
24. Wong R, Lam E, Bramante CT, et al. Does COVID-19 infection increase the risk of diabetes? Current evidence. Curr Diab Rep 2023; 23: 207–216. doi: 10.1007/s11892-023-01515-1.


Termedia
O Wydawnictwie Oferty Newsletter Kontakt Praca
Polityka prywatności Polityka reklamowa Napisz do nas Nota prawna Regulamin
Na skróty
Aktualności Czasopisma Książki eBooki Konferencje i webinary Podcasty Mednauka
Serwisy
KONGRES TOP MEDICAL TRENDS Menedżer Zdrowia Lekarz POZ Choroby rzadkie Dermatologia Diabetologia Onkologia Neurologia Reumatologia Gastroenterologia Pulmonologia Ginekologia Kurier Medyczny Zalecenia i rekomendacje e-Praktyka Leczenia Ran Warto wiedzieć Biblioteka podcastów
e-Akademia
e-Akademia Zaburzeń Mikrobioty e-Akademia POChP e-Akademia Chorób Naczyń
© 2026 Termedia Sp. z o.o.
Developed by Termedia.